Prevalence of occult hepatitis C virus infection in hemodialysis patients

Masomeh Bayani1, Mohammad Reza Hasanjani Roushan1, Mohammad Jafar Soleimani Amiri1

  • 1Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Insights

Occult hepatitis C infection (OCI) affects hemodialysis patients, with prevalence linked to longer dialysis duration. This study found OCI in 2.65% of patients, highlighting transmission risks in dialysis settings.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Nephrology

Background:

  • Hemodialysis patients are at risk of viral infections, including occult hepatitis C virus (HCV) infection (OCI).
  • OCI is defined by the presence of HCV in tissues like the liver and PBMCs, despite negative serum tests and normal liver enzymes.
  • Understanding OCI prevalence in hemodialysis patients is crucial for infection control.

Purpose of the Study:

  • To determine the prevalence of occult hepatitis C infection (OCI) in patients undergoing hemodialysis.
  • To investigate potential associations between OCI and factors such as age, sex, and duration of dialysis.

Main Methods:

  • A cross-sectional study was conducted on 302 hemodialysis patients in Mazandaran province, Iran (2012-2014).
  • Serum and peripheral blood mononuclear cells (PBMCs) were tested for HCV RNA using real-time PCR.
  • Patients with positive HCV antibodies were excluded prior to enrollment.

Main Results:

  • Eight patients (2.65%) were diagnosed with occult hepatitis C infection (OCI).
  • A significant association was found between the duration of hemodialysis and the prevalence of OCI (P=0.017).
  • No significant association was observed between OCI and patient age or sex.

Conclusions:

  • The prevalence of occult hepatitis C infection (OCI) in hemodialysis patients was found to be 2.65%.
  • Longer duration of dialysis is a significant risk factor for developing OCI in this population.
  • These findings underscore the importance of vigilant screening and infection control measures in hemodialysis units.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
185
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
407
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
28
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
267
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
146
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
19